Pfizer Inc.

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
Registration as it was on 13 Jun 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,250,000€ - 1,499,999€

Financial year: Jan 2021 - Dec 2021

Lobbyists (Full time equivalent)

2 Fte (5)

Lobbyists with EP accreditation

6

High-level Commission meetings

17

Lobbying Costs over the years

  • Info

    Pfizer Inc.   (PFE)

    EU Transparency Register

    4263301811-33 First registered on 18 Dec 2008

    Goals / Remit

    At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. In 2021, Pfizer's full year revenue was $81.3 billion, with $10.5 billion invested in research and development. To learn more, please visit us at www.pfizer.com.

    Main EU files targeted

    Revision of general EU pharmaceutical legislation, digital health e.g. European Health Data Space, AI Regulation, gene therapy, pharmaceutical strategy, Pediatric & Orphan Review, Vaccination policy, HTA Regulation, Pharmaceuticals in the Environment, IMI and research programs, EU trade negotiations, corporate tax, Covid-19 vaccines & therapeutics procurement, HERA & bio-preparedness.

    Address

    Head Office
    East 42nd Street, 235
    New York NY 10017
    UNITED STATES
    EU Office
    Boulevard de la Plaine, 17
    Brussels 1050
    BELGIUM

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    50%3
    25%2

    Lobbyists (Full time equivalent)

    2

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    6 accreditations were / are live (in bold) for the selected state of 04 Oct 2022

    Name Start date End Date
    Mr CHARLES FAID 09 Sep 2022 07 Sep 2023
    Mr Riccardo ROVERA 01 Jul 2022 30 Jun 2023
    Mr ANDREA CHIARELLO 25 Jun 2022 23 Jun 2023
    Ms Eva GRUT AANDAHL 25 Mar 2022 24 Mar 2023
    Mr Yordan Aleksandrov 24 Mar 2022 23 Mar 2023
    Mr Franjo CAIC 07 Jul 2021 21 Sep 2021
    Mr ANDREA CHIARELLO 06 Jul 2021 05 Jul 2022
    Ms HEIKE GALBRAITH 06 Mar 2021 04 Mar 2022
    Ms Eva GRUT AANDAHL 06 Mar 2021 04 Mar 2022
    Mr ANDREA CHIARELLO 14 Aug 2020 13 Aug 2021
    Mr Franjo CAIC 06 Aug 2020 27 Aug 2021
    Ms EVA GRUT AANDAHL 12 Feb 2020 28 Feb 2021
    Mr CHARLES FAID 12 Feb 2020 28 Feb 2021
    Ms HEIKE GALBRAITH 12 Feb 2020 28 Feb 2021
    Mr Matthew Thomas CLAY 14 Dec 2019 11 Dec 2020
    Mr ANDREA CHIARELLO 06 Sep 2019 04 Sep 2020
    Mr Franjo CAIC 22 Aug 2019 21 Aug 2020
    Ms EVA GRUT AANDAHL 06 Feb 2019 29 Feb 2020
    Mr CHARLES FAID 06 Feb 2019 29 Feb 2020
    Ms HEIKE GALBRAITH 06 Feb 2019 29 Feb 2020
    Mr Matthew Thomas CLAY 12 Dec 2018 11 Dec 2019
    Mr ANDREA CHIARELLO 26 Sep 2018 25 Sep 2019
    Ms EVA GRUT AANDAHL 03 Feb 2018 01 Feb 2019
    Mr CHARLES FAID 03 Feb 2018 01 Feb 2019
    Ms HEIKE GALBRAITH 03 Feb 2018 01 Feb 2019
    Mr Matthew Thomas CLAY 09 Jan 2018 08 Jan 2019
    Mr ANDREA CHIARELLO 01 Sep 2017 31 Aug 2018
    Ms EVA GRUT AANDAHL 21 Feb 2017 13 Feb 2018
    Mr CHARLES FAID 21 Feb 2017 14 Feb 2018
    Ms HEIKE GALBRAITH 21 Feb 2017 14 Feb 2018
    Mr Matthew Thomas CLAY 23 Jan 2017 11 Jan 2018
    Mr ANDREA CHIARELLO 30 Sep 2016 28 Sep 2017
    Ms EVA GRUT AANDAHL 10 Mar 2016 09 Mar 2017
    Mr CHARLES FAID 10 Mar 2016 09 Mar 2017
    Ms HEIKE GALBRAITH 10 Mar 2016 09 Mar 2017
    Mr Matthew Thomas CLAY 15 Jan 2016 14 Jan 2017
    Mr ANDREA CHIARELLO 28 Aug 2015 31 Aug 2016
    Ms EVA GRUT AANDAHL 19 Feb 2015 17 Feb 2016
    Mr CHARLES FAID 25 Feb 2015 18 Feb 2016
    Ms HEIKE GALBRAITH 25 Feb 2015 23 Feb 2016
    Mr Matthew Thomas CLAY 09 Jan 2015 07 Jan 2016
    Mr Matthew Thomas CLAY 16 Jan 2014 10 Jan 2015
    Ms EVA GRUT AANDAHL 14 Feb 2013 12 Feb 2014
    Mr Matthew Thomas CLAY 17 Jan 2013 05 Dec 2013
    Mr Matthew Thomas CLAY 20 Dec 2011 31 Dec 2012

    Complementary Information

    3 colleagues are full-time engaged in the Brussels office and spend approx. 50% of their time on EU affairs. Moreover, 2 other colleagues engaged in Brussels spend about 25%. Finally, a number of colleagues (most not based in Brussels) spend between 0-10%< of their time.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    In 2021 Pfizer was a member of: EFPIA, Vaccines Europe, EuropaBio, Amcham EU, BusinessEurope, TABC & AECA.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2021 - Dec 2021

    Lobbying costs for closed financial year

    1,250,000€ - 1,499,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    rpp group 25,000€ - 49,999€
    zn consulting 100,000€ - 199,999€
    fleishman-hillard 100,000€ - 199,999€
    hanbury strategy 10,000€ - 24,999€

    Intermediaries for current year

    Name
    hanbury strategy
    fleishman-hillard
    zn consulting

    Closed year Costs

    1,250,000€ - 1,499,999€

    Other financial info

    The amount declared in answer (c) includes: relevant percentage of trade associations' work, consultants as declared, percentage of colleagues' fully loaded salary and office expenses.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Other activities

    Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment

  • Meetings

    Meetings

    17 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't publish information about such meetings. All information below comes from European Commission web pages.

Download this datacard